BPA Call W81K0222A0010-HT009026FG1040072
- Not listed
- The Defense Health Agency awarded a $24,246.50 firm fixed price Blanket Purchase Agreement (BPA) call contract to Prolacta Bioscience, Inc. on July 28, 2025, with completion scheduled for September 30, 2025. This task order is for the provision of Prolacta breastmilk products specifically designed for administration to critically ill and premature infants in neonatal intensive care units (NICUs). The contract carries no set-aside designation and will be performed at the contractor's facility...
- This is a firm fixed price blanket purchase agreement (BPA) call contract awarded by the Defense Health Agency (DHA) to Prolacta Bioscience, Inc., a for-profit manufacturer of human milk-based nutritional products for premature and critically ill infants. The contract, valued at $15,817.86, is for the purchase of Prolacta's breastmilk supplementation products to be used in the neonatal intensive care unit (NICU) at Tripler Army Medical Center. The contract has a period of performance through...
- The Defense Health Agency awarded a firm fixed price purchase order to Prolacta Bioscience, Inc. for $163,374.46 to provide human milk-based neonatal nutrition products. This award was not set aside for any special business category. Prolacta Bioscience is a private, for-profit manufacturer that supplies specialized breastmilk-derived formulas, supplements, and other nutritional therapies to support premature and critically ill infants treated at military medical facilities. The award is...
- This firm fixed price contract was awarded by the Defense Health Agency to Prolacta Bioscience, Inc. to provide Prolacta's proprietary human milk-based nutritional products for use with infants in the neonatal intensive care unit (NICU) at Tripler Army Medical Center. The $15,536.12 contract is a call against a larger $250,000 single-award blanket purchase agreement for donor human milk and a $1.75 million single-award BPA for various human milk-based products to support military treatment...
- The Department of the Army Medical Command awarded a firm fixed price blanket purchase agreement (BPA) call to Prolacta Bioscience, Inc., a manufacturer of human milk-based neonatal nutrition products. The $150,000 award provides specialized nutritional support for premature and critically ill infants treated at military medical facilities. Prolacta Bioscience supplies a range of human milk-derived items, including donor human milk, pre-natal formulas, food supplements, and breastmilk...
- <p>The Defense Health Agency (DOD) awarded a $250,000 Firm Fixed Price Blanket Purchase Agreement Call contract to Prolacta Bioscience, Inc. to provide Human Milk Products. Prolacta Bioscience, Inc. will perform the work at their location in Bassett, California. The period of performance for this contract is September 30, 2023 through September 30, 2023.</p>
- This contract was awarded to Prolacta Bioscience, Inc. by the Department of the Army Medical Command. The contract, valued at $150,000.00, is for the provision of human milk-based neonatal nutrition products to support premature and critically ill infants treated at military medical facilities. The contract is a Blanket Purchase Agreement (BPA) call, with a firm fixed price pricing type, and a performance period ending on September 30, 2022. Prolacta Bioscience, a manufacturer of goods, has...
- This is a federal contract award to Prolacta Bioscience, Inc., a for-profit manufacturer of human milk-based nutritional products for premature and critically ill infants. The contract, valued at $24,533.58, is a Blanket Purchase Agreement (BPA) call with the Defense Health Agency (DHA), a component of the Department of Defense. The contract is for the provision of Prolacta's donor breastmilk products to be used in Neonatal Intensive Care Units (NICUs) at military medical facilities. This is not...
- This federal contract award to Prolacta Bioscience, Inc. is for PROLACT+6 HMF and PROLACTA NEONATAL FORMULA products. The $3,254,150.28 fixed-price contract was awarded on October 1, 2019 by the Defense Health Agency, a defense agency, and has an ultimate completion date of September 30, 2024. The contract does not have a set-aside designation. Prolacta Bioscience, a for-profit manufacturer of human milk-based nutritional products, is the prime contractor. The award is associated with three...
- The Defense Logistics Agency Troop Support Pacific awarded a $1,933.40 firm fixed-price call order to At Fresh Pte. LTD. on August 7, 2025, for the procurement of reduced/low-fat, shelf-stable ultra-high-temperature (UHT) milk. The award was issued without a set-aside designation and is scheduled for completion by September 9, 2025. This call order was executed under At Fresh Pte. LTD.'s existing Indefinite-Delivery, Indefinite-Quantity Blanket Purchase Agreement with DLA Troop Support...
- W81K0222A0010Blanket Purchase Agreement
- W81K0222A0010-HT009026FG1040072BPA Call
The Defense Health Agency awarded a $35,818.34 firm fixed price call under an existing Blanket Purchase Agreement to Prolacta Bioscience, Inc. for the purchase of human milk-based nutritional products to support premature infants in the Neonatal Intensive Care Unit at Tripler Army Medical Center. The contract, which commenced on October 1, 2025, and extends through September 30, 2026, requires no set-aside designation. Prolacta Bioscience, headquartered in City of Industry, California, specializes in manufacturing advanced breastmilk-derived fortifiers, supplements, and donor human milk products specifically engineered to meet the complex nutritional needs of extremely low birth weight and premature infants. The products delivered under this call will support critical neonatal care operations within the military healthcare system. This award represents a task order issued under one of three significant Blanket Purchase Agreements that the Defense Health Agency maintains with Prolacta Bioscience, including a $1.75 million BPA established in October 2022, a $500,000 BPA for donor human milk established in September 2023, and a $1.9 million BPA established in December 2024. These indefinite delivery vehicles enable the Defense Health Agency to procure specialized human milk-based nutritional products across multiple military medical facilities on a firm fixed price basis. Prolacta Bioscience's exclusive federal contract history with the Defense Health Agency underscores the specialized nature of these products and their critical importance to neonatal care delivery within the military healthcare system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $35.8k | 10/1/25 |